These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2117457)

  • 1. Enantioselective metabolism of encainide by rat liver microsomes.
    Jajoo HK; Prakash C; Mayol RF; Blair IA
    Biochem Pharmacol; 1990 Aug; 40(4):893-5. PubMed ID: 2117457
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of enantiomers of the antiarrhythmic drug encainide and its major metabolites by chiral derivatization and high-performance liquid chromatography.
    Prakash C; Jajoo HK; Blair IA; Mayol RF
    J Chromatogr; 1989 Sep; 493(2):325-35. PubMed ID: 2511218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encainide for cardiac arrhythmias.
    Med Lett Drugs Ther; 1987 May; 29(740):50-2. PubMed ID: 2437434
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical importance of metabolites of antiarrhythmic drugs.
    Kates RE; Woosley RL; Harrison DC
    Am J Cardiol; 1984 Jan; 53(1):248-51. PubMed ID: 6419577
    [No Abstract]   [Full Text] [Related]  

  • 5. Encainide and metabolites analysis in serum or plasma using a reversed-phase high-performance liquid chromatographic technique.
    Dasgupta A; Rosenzweig IB; Turgeon J; Raisys VA
    J Chromatogr; 1990 Mar; 526(1):260-5. PubMed ID: 2111331
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolite cumulation during long-term oral encainide administration.
    Kates RE; Harrison DC; Winkle RA
    Clin Pharmacol Ther; 1982 Apr; 31(4):427-32. PubMed ID: 6800679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac arrhythmia suppression trial.
    Galløe AM; Graudal N
    N Engl J Med; 1991 Aug; 325(8):584-5. PubMed ID: 1906989
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of encainide.
    Jaillon P
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():561-5. PubMed ID: 2125833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites of antiarrhythmic drugs: are they clinically important?
    Kates RE
    Ration Drug Ther; 1986 May; 20(5):1-5. PubMed ID: 3097754
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of genetic polymorphism on the metabolism and disposition of encainide in man.
    Wang T; Roden DM; Wolfenden HT; Woosley RL; Wood AJ; Wilkinson GR
    J Pharmacol Exp Ther; 1984 Mar; 228(3):605-11. PubMed ID: 6423808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative metabolism of encainide: polymorphism, pharmacokinetics and clinical considerations.
    McAllister CB; Wolfenden HT; Aslanian WS; Woosley RL; Wilkinson GR
    Xenobiotica; 1986 May; 16(5):483-90. PubMed ID: 3090789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.
    Hemsworth PD; Campbell TJ
    Br J Pharmacol; 1989 Jun; 97(2):619-25. PubMed ID: 2503225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselectivity in the metabolism of drobuline (d1--1- (isopropylamino) -4,4-diphenyl-2-butanol) a new anti-arrhythmic agent.
    Murphy PJ; Williams TL; Smallwood JK; Bellamy G; Molloy BB
    Life Sci; 1978 Jul; 23(4):301-11. PubMed ID: 692260
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of encainide and its metabolites by high-performance liquid chromatography.
    Selinger K; Crawhall JC
    J Pharm Biomed Anal; 1989; 7(3):355-9. PubMed ID: 2518704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impressions and certainties concerning the harmful effects of anti-arrhythmic drugs].
    Sanna G
    G Ital Cardiol; 1985 Oct; 15(10):937-41. PubMed ID: 3937762
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial uptake of encainide and its two major metabolites, O-demethyl encainide and 3-methoxy-O-demethyl encainide, in the dog.
    Latini R; Gillis AM; Kates RE
    J Cardiovasc Pharmacol; 1984; 6(4):663-7. PubMed ID: 6206322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of encainide on in vivo drug metabolism in the rat.
    Svensson CK; Knowlton PW
    Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):285-8. PubMed ID: 3110886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antiarrhythmic actions of encainide and its major metabolites.
    Gomoll AW; Byrne JE; Mayol RF
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):277-97. PubMed ID: 3092755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega- and (omega-1)-hydroxylation of 4-chloropropionanilide by rabbits and rabbit liver microsomes.
    Kiese M; Lenk W
    Biochem Pharmacol; 1973 Oct; 22(20):2565-74. PubMed ID: 4763592
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers.
    Turgeon J; Funck-Brentano C; Gray HT; Pavlou HN; Prakash C; Blair IA; Roden DM
    Clin Pharmacol Ther; 1991 May; 49(5):488-96. PubMed ID: 1903098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.